UBS Group AG - SUNSHINE BIOPHARMA INC ownership

SUNSHINE BIOPHARMA INC's ticker is and the CUSIP is 867781403. A total of 12 filers reported holding SUNSHINE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SUNSHINE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$010.0%0.00%
Q2 2023$0
-100.0%
1
-100.0%
0.00%
Q1 2023$1,760
-61.9%
2,407
-66.6%
0.00%
Q4 2022$4,6157,210
+720900.0%
0.00%
Q3 2022$010.0%0.00%
Q2 2022$0
-100.0%
1
-100.0%
0.00%
Q1 2022$6,0002,4340.00%
Other shareholders
SUNSHINE BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,100$183,1040.01%
Virtu Financial LLC 36,660$230.00%
BANK OF AMERICA CORP /DE/ 13,872$8,8780.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 20,179$120.00%
NATIONAL BANK OF CANADA /FI/ 6,042$3,8670.00%
BANK OF MONTREAL /CAN/ 30,000$21,6000.00%
New England Capital Financial Advisors LLC 500$4900.00%
UBS Group AG 7,210$4,6150.00%
OSAIC HOLDINGS, INC. 6,628$4,0000.00%
View complete list of SUNSHINE BIOPHARMA INC shareholders